Skip to main content
. Author manuscript; available in PMC: 2016 May 27.
Published in final edited form as: Alzheimers Dement (Amst). 2016;3:43–50. doi: 10.1016/j.dadm.2016.02.005

Figure 2. Ratios of plasma sphingolipids by defined among individuals with autopsy-confirmed Lewy Body pathology or AD pathology.

Figure 2

Standardized methods for sampling and neuropathologic examination were performed according to the third report of the DLB consortium (CDLB) and the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) Guidelines. S1P, sphingosine-1-phosphate; CN, Cognitively normal, normal aging pathology; DLB, Dementia with Lewy Bodies (high or intermediate likelihood); AD, Dementia with Alzheimer’s disease pathology.